Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer PFE will report its third-quarter 2025 earnings on Nov. 4, before market open. The Zacks Consensus Estimate for sales ...

Pfizer has long been a solid dividend payer, having raised its dividend annually for 16 years. Its yield is high because the stock price has fallen in recent years. That has given it an appealing ...

PFEon is the Ondo Tokenized version of Pfizer, giving tokenholders economic exposure similar to holding PFE and reinvesting any dividends. Ondo tokenized stocks enable non-US retail and institutional ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $13.0 to $26.5 for Pfizer over the last 3 months.

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $30.0 for Pfizer during the past quarter. Looking at the volume ...

Pfizer files lawsuits against Novo over $9B Metsera bid, challenging 30-month timeline. Court hearing Tuesday as deadline ...

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something causes shares to slide right back down.

Pfizer has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s ...

Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options chain ...